CompoAtlas

SynerMag 2.0

Natural health product licensed in Canada

Licence holder
ATP ATHLÉTIQUE ET THÉRAPEUTIQUE PHARMA INC. ou ATP ATHLETIC AND THERAPEUTIC PHARMA INC.
NPN or DIN-HM
80084530
Status
Inactive licence
Licence date
17 April 2018
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Magnésium

Source : Glycinate de magnésium

74.25 milligramme74,250 µg
Magnésium

Source : Taurate de magnésium

74.25 milligramme74,250 µg
Magnésium

Source : Malate de magnésium

74.25 milligramme74,250 µg
Vitamine B6

Source : Pyridoxal 5'-phosphate

10 milligramme10,000 µg

Non-medicinal ingredients

Hydroxypropylméthylcellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 Tous les jours

Uses authorised in Canada

Helps in the development and maintenance of bones and teeth. Helps in energy metabolism, tissue formation and bone development. Helps to maintain proper muscle function, including the heart muscle. Helps to maintain normal electrolyte balance. Helps to form red blood cells.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80084530

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line